3,204,275 casEn 2020, les formations sanitaires du Mali ont enregistré 3 204 275 cas confirmés de paludisme avec 1480 décès.
Malipaludismeobserved 2020HAL · Unilimdocument of 214 observations
Gold tier: mechanically validated evidence, with its primary source.
1,197 evidence items · page 48 / 48
3,204,275 casEn 2020, les formations sanitaires du Mali ont enregistré 3 204 275 cas confirmés de paludisme avec 1480 décès.
Malipaludismeobserved 2020HAL · Unilimdocument of 214 observations
55 %La prévalence de la mutation -374T était de 55 % chez les individus non infectés par Plasmodium falciparum dans la population étudiée.
MalipaludismeHAL · Unilimdocument of 31 observations
1.154 per_1000_person_weeksMalaria incidence in the Kidal region was 1.154 cases per 1,000 person-weeks in 2022.
Malipaludismeobserved 2022HAL · Unilimdocument of 80 observations
The prevalence of dyspnea and congestive heart failure was low and did not differ significantly between sickle cell disease patients and healthy controls in Cameroon, Mali, and Senegal.
Cameroun · Mali · Sénégaldrépanocytosepublished 2018Frontiers in MedicineOpenAlexdocument of 10 observationsDOI 10.3389/fmed.2018.00323
8.66 %The prevalence of HbAC among 3648 newborns in Mali was 8.66%.
MaliHbACobserved April–August 2021HAL · Unilimdocument of 103 observations
3 casesThree cases of uncomplicated clinical malaria were encountered in the artesunate-amodiaquine arm of the trial.
Malipaludismepublished 2018Parasite epidemiology and controleurope_pmcdocument of 6 observations
60 %En 2018, seulement 60 % des cas de paludisme avaient été confirmés dans le pays par microscopie optique.
Malipaludismeobserved 2018HAL · Unilimdocument of 214 observations
79.66 %HemotypeSC® had a positive predictive value (PPV) of 79.66% (95% CI: 69.39–89.93) to detect sickle cell disease.
MalidrépanocytoseHAL · Unilimdocument of 103 observations
22.8 %The median annual intermittent preventive treatment in pregnancy (IPTp) coverage rate increased from 22.8% in 2017–2018 to 31.9% in 2021–2022.
Malipaludismeobserved 2017–2018HAL · Unilimdocument of 111 observations
0.76 %In Tombouctou health district, 532 confirmed cases of COVID-19 represented 0.76% of the general population.
MaliCOVID-19HAL · Unilimdocument of 88 observations
The modeled outcome was the total number of malaria cases.
MalipaludismeHAL · Unilimdocument of 80 observations
0 casesNo cases of cerebral vasculopathy were observed in S/β+ thalassemia patients.
Malicerebral vasculopathy · S/β+ thalassemiapublished 2013BloodOpenAlexdocument of 10 observations
75 %En 2018, Plasmodium vivax représentait 75 % des cas de paludisme en Amérique.
Malipaludismeobserved 2018HAL · Unilimdocument of 214 observations
6,311 casesThe Kidal region reported a total of 6,311 malaria cases according to the national health information system from week 23 in 2024 (May) to week 5 in 2025 (February).
Malipaludismeobserved 2024-2025HAL · Unilimdocument of 80 observations
80.5 %Among COVID-19 patients (n = 266), 80.5% responded to the S antigen.
MaliCOVID-19HAL · Unilimdocument of 67 observations
98.4 %The day-42 PCR-adjusted cure rate estimates were 98.4% in the dihydroartemisinin-piperaquine arm.
Malipaludismepublished 2018Malaria journaleurope_pmcdocument of 9 observations
33.5 %The seroprevalence of SARS-CoV-2 in the urban commune of Tombouctou was 33.5% (95% CI: 30.4% to 36.6%).
MaliCOVID-19observed January 2021HAL · Unilimdocument of 88 observations
259 participantsA total of 259 participants were enrolled in this study from three different altitudes.
Malipaludismeobserved 2013 to 2014published 2017Infectious diseases of povertyeurope_pmcdocument of 6 observations
IFN-γ level was positively associated with parasite clearance.
Malipaludismepublished 2023Cytokineeurope_pmcdocument of 3 observations
82.2 %The prevalence of children who cleared their mutant parasites was 82.2% in Bandiagara and 67.4% in Kolle.
Malipaludismepublished 2023Cytokineeurope_pmcdocument of 3 observations
33.5 %The crude seroprevalence of SARS-CoV-2 in Tombouctou was 33.5% (95% CI: 30.4% to 36.6%) among 923 tested individuals aged at least 1 year.
MaliCOVID-19observed January 2021HAL · Unilimdocument of 88 observations
12 %Sickle cell disease prevalence in Mali is estimated at 12%.
Malidrépanocytosepublished 2009Мир науки, культуры, образованияOpenAlexdocument of 12 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.